Matrix metalloproteinases and their tissue inhibitor after reperfused ST-elevation myocardial infarction treated with doxycycline. Insights from the TIPTOP trial
- 1 October 2015
- journal article
- research article
- Published by Elsevier in International Journal of Cardiology
- Vol. 197, 147-153
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- Chronic Matrix Metalloproteinase Inhibition Following Myocardial Infarction in Mice: Differential Effects on Short and Long-Term SurvivalThe Journal of Pharmacology and Experimental Therapeutics, 2006
- Relevance of matrix metalloproteinases and their inhibitors after myocardial infarction: A temporal and spatial windowCardiovascular Research, 2006
- Targeted deletion or pharmacological inhibition of MMP-2 prevents cardiac rupture after myocardial infarction in miceJournal of Clinical Investigation, 2005
- Accelerated LV remodeling after myocardial infarction in TIMP-1-deficient mice: effects of exogenous MMP inhibitionAmerican Journal of Physiology-Heart and Circulatory Physiology, 2005
- Selective Targeting and Timing of Matrix Metalloproteinase Inhibition in Post-Myocardial Infarction RemodelingCirculation, 2003
- Ventricular Remodeling After Infarction and the Extracellular Collagen MatrixCirculation, 2003
- Imbalance Between Tissue Inhibitor of Metalloproteinase-4 and Matrix Metalloproteinases During Acute Myoctardial Ischemia-Reperfusion InjuryCirculation, 2003
- Left Ventricular Remodeling After Primary Coronary AngioplastyCirculation, 2002
- Intracellular Action of Matrix Metalloproteinase-2 Accounts for Acute Myocardial Ischemia and Reperfusion InjuryCirculation, 2002
- Cardiac remodeling—concepts and clinical implications: a consensus paper from an international forum on cardiac remodelingJACC, 2000